BlackRock Fund Advisors’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.87M | Buy |
280
+45
| +19% | +$300K | ﹤0.01% | 3177 |
|
|
2016
Q3 | $3.53M | Buy |
235
+10
| +4% | +$150K | ﹤0.01% | 3016 |
|
|
2016
Q2 | $3.54M | Buy |
225
+209
| +1,306% | +$3.29M | ﹤0.01% | 3002 |
|
|
2016
Q1 | $339K | Sell |
16
-2
| -11% | -$42.4K | ﹤0.01% | 3306 |
|
|
2015
Q4 | $352K | Buy |
18
+1
| +6% | +$19.6K | ﹤0.01% | 3343 |
|
|
2015
Q3 | $329K | Buy |
17
+1
| +6% | +$19.4K | ﹤0.01% | 3305 |
|
|
2015
Q2 | $388K | Sell |
16
-2
| -11% | -$48.5K | ﹤0.01% | 3276 |
|
|
2015
Q1 | $340K | Sell |
18
-1
| -5% | -$18.9K | ﹤0.01% | 3348 |
|
|
2014
Q4 | $242K | Buy |
19
+5
| +36% | +$63.7K | ﹤0.01% | 3430 |
|
|
2014
Q3 | $222K | Buy |
14
+2
| +17% | +$31.7K | ﹤0.01% | 3433 |
|
|
2014
Q2 | $185K | Hold |
12
| – | – | ﹤0.01% | 3514 |
|
|
2014
Q1 | $268K | Buy |
12
+4
| +50% | +$89.3K | ﹤0.01% | 3385 |
|
|
2013
Q4 | $101K | Buy |
8
+1
| +14% | +$12.6K | ﹤0.01% | 3573 |
|
|
2013
Q3 | $106K | Hold |
7
| – | – | ﹤0.01% | 3542 |
|
|
2013
Q2 | $100K | Buy |
+7
| New | +$100K | ﹤0.01% | 3525 |
|